Transforming Pharma Consulting: The Fractional Model with Mary Hames
In this conversation, Mary Hames, CEO and founder of BioLogic Pharma Solutions, discusses her journey in the biotech and pharmaceutical consulting industry. She explains the fractional model of consulting, which allows smaller companies to access expertise without the financial burden of hiring full-time staff. Mary shares her entrepreneurial journey, the importance of company culture, and the challenges of consulting in a dynamic environment. She also highlights the significance of trust in startups and her aspirations for the future of her company.
00:00 Introduction to BioLogic Pharma Solutions
03:01 The Fractional Model in Biotech Consulting
06:00 Navigating Uncertainty in Drug Development
09:04 Mary's Entrepreneurial Journey
11:50 Vision for the Future of Biotech Consulting
14:45 Challenges in Consulting and Growth
17:57 The Importance of Trust in Entrepreneurship
26:49 The Importance of Delegation in Business
28:02 Navigating Client Acquisition and Marketing Strategies
30:35 Effective Client Engagement and Presentation Techniques
34:12 Understanding Market Dynamics and Client Feedback
36:11 Identifying the Sweet Spot in the Drug Development Process
39:25 Building a Flexible Workforce and Consultant Relationships
40:19 Future Aspirations and Growth Strategies for the Company
46:12 Reflections on the Entrepreneurial Journey
Guest Information:
00:00 Introduction to BioLogic Pharma Solutions
03:01 The Fractional Model in Biotech Consulting
06:00 Navigating Uncertainty in Drug Development
09:04 Mary's Entrepreneurial Journey
11:50 Vision for the Future of Biotech Consulting
14:45 Challenges in Consulting and Growth
17:57 The Importance of Trust in Entrepreneurship
26:49 The Importance of Delegation in Business
28:02 Navigating Client Acquisition and Marketing Strategies
30:35 Effective Client Engagement and Presentation Techniques
34:12 Understanding Market Dynamics and Client Feedback
36:11 Identifying the Sweet Spot in the Drug Development Process
39:25 Building a Flexible Workforce and Consultant Relationships
40:19 Future Aspirations and Growth Strategies for the Company
46:12 Reflections on the Entrepreneurial Journey
Guest Information:
- Guest's Name: Mary Hames
- Guest's Title/Position: Founder & CEO
- Guest's Linkedin: https://www.linkedin.com/in/mary-hames-phd-biologicpharmasolutions/
- Company / Affiliation: BioLogic Pharma Solutions https://biologicpharmasolutions.com/
- Guest's Bio: Mary Hames is a scientist-turned-strategic leader with over a decade of experience guiding biotech and pharma companies from breakthrough science to real-world impact. With deep expertise in neurology, rare diseases, and radiopharmaceuticals, Mary has held roles spanning R&D, medical affairs, diagnostics, and executive leadership. She specializes in translating complex science into strategic action—building scalable systems, aligning cross-functional teams, and accelerating development and launch readiness. Known for her clarity, energy, and execution, Mary thrives in high-stakes environments where innovation meets urgency.
Takeaways:
- The fractional model allows companies to access expertise without full-time hires.
- Building a company culture is essential for employee satisfaction.
- Consulting can be lonely, but teamwork helps mitigate that.
- Marketing strategies include presentations and SEO efforts.
- Trust is crucial for entrepreneurs to delegate responsibilities.
- The future of BioLogic includes becoming a go-to firm for pre-commercial products.
- Navigating uncertainty in drug development is a common challenge.
- Mary's entrepreneurial journey includes learning from past failures.
- The sweet spot for consulting is between phase two and three of drug development.
Creators and Guests
Host
Heath Fletcher
With over 30 years in creative marketing and visual storytelling, I’ve built a career on turning ideas into impact. From brand transformation to media production, podcast development, and outreach strategies, I craft compelling narratives that don’t just capture attention—they accelerate growth and drive measurable results.
Guest
Mary Hames
Mary Hames is a scientist-turned-strategic leader with over a decade of experience guiding biotech and pharma companies from breakthrough science to real-world impact. With deep expertise in neurology, rare diseases, and radiopharmaceuticals, Mary has held roles spanning R&D, medical affairs, diagnostics, and executive leadership. She specializes in translating complex science into strategic action—building scalable systems, aligning cross-functional teams, and accelerating development and launch readiness. Known for her clarity, energy, and execution, Mary thrives in high-stakes environments where innovation meets urgency.